CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 219 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02796274
NCT02796274N/ACompleted

Historical Case Record Survey of Visual Acuity Data From Patients With Leber's Hereditary Optic Neuropathy (LHON)

Santhera Pharmaceuticals·observational·Posted Jun 10, 2016·Updated Jan 30, 2020

In Brief

An observational study for Leber's Hereditary Optic Neuropathy (LHON). Completed, enrolled 219 participants across 21 sites in 7 countries.

Detailed Summary

The purpose of this survey is to collect visual acuity data from patients with LHON in order to establish the clinical course (natural history) and visual acuity outcomes in patients with a genetically confirmed diagnosis of LHON. In addition, this survey will generate data that will serve as comparator for the open-label study SNT-IV-006.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesBelgium, France, Germany, Italy, Netherlands, Norway, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 10, 2016
Enrollment StartMay 1, 2016
Primary CompletionMar 1, 2018
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 10.1 years ago